Meta-analyses of FibroTest diagnostic value in chronic liver disease (Q33302708)

25 July 2017

0 references

Meta-analyses of FibroTest diagnostic value in chronic liver disease (English)

1 reference

25 July 2017

0 references

0 references

1 reference

chronic liver disease

0 references

author

Françoise Imbert-Bismut

6

Françoise Imbert-Bismut

0 references

Thierry Poynard

Thierry Poynard

1

0 references

Patrice Cacoub

Patrice Cacoub

12

0 references

Mona Munteanu

Mona Munteanu

14

0 references

Laurent Castera

Laurent Castera

4

0 references

Dominique Thabut

8

Dominique Thabut

1 reference

25 July 2017

5

Vlad Ratziu

1 reference

25 July 2017

13

Djamila Messous

1 reference

25 July 2017

2

Rachel Morra

1 reference

25 July 2017

7

Sylvie Naveau

1 reference

25 July 2017

15

Victor de Ledinghen

1 reference

25 July 2017

Philippe Halfon

3

1 reference

25 July 2017

Françoise Imbert-Bismut

6

1 reference

25 July 2017

Didier Lebrec

9

1 reference

25 July 2017

Fabien Zoulim

10

1 reference

25 July 2017

Marc Bourliere

11

1 reference

25 July 2017

15 October 2007

1 reference

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

40

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

start time

15 October 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-7-40

0 references

cites work

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Noninvasive measures of liver fibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Role of liver biopsy in management of chronic hepatitis C: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Publication bias in clinical research

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

28 July 2018

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

A novel panel of blood markers to assess the degree of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

A comparison of fibrosis progression in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Sampling variability of liver fibrosis in chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175505

Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-7-40

Assessing fibrosis without a liver biopsy: are we there yet?

21 January 2018

1 reference

12 December 2020

Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

1 reference

12 December 2020

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

12 December 2020

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

CYP2E1: from ASH to NASH

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-7-40

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference